Nebivolol, a beta adrenergic receptor antagonist blocks angiotensin II-mediated signaling in heart [abstract]

dc.contributor.advisor	Pulakat, Lakshmi	eng
dc.contributor.author	Gul, Rukhsana	eng
dc.contributor.author	DeMarco, Vincent G.	eng
dc.contributor.author	Arnold, Shannon	eng
dc.contributor.author	Whaley-Connell, Adam T.	eng
dc.contributor.author	Sowers, James R. (James Russell), 1942-	eng
dc.contributor.corporatename	University of Missouri--Columbia. School of Medicine	eng
dc.contributor.meetingname	Health Sciences Research Day (2010 : University of Missouri)	eng
dc.date.issued	2010	eng
dc.description.abstract	We recently showed that Nebivolol, a [beta]-adrenergic receptor (AR) antagonist attenuates myocardial oxidative stress and promotes insulin metabolic signaling in 9 week old Zucker obese (ZO) insulin resistant rats. Here, we demonstrate that Nebivolol suppresses angiotensin II type I receptor (AT1R)-mediated signaling in ZO hearts as well as in HL-1 cardiomyocytes.	eng
dc.format.extent	1 page	eng
dc.identifier.uri	http://hdl.handle.net/10355/9368
dc.language	English	eng
dc.relation.ispartofcommunity	University of Missouri--Columbia. Health Sciences Research Day	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.	eng
dc.subject	blood pressure	eng
dc.subject	cardiac disorders	eng
dc.subject.FAST	Adrenergic beta blockers	eng
dc.title	Nebivolol, a beta adrenergic receptor antagonist blocks angiotensin II-mediated signaling in heart [abstract]	eng
dc.type	Abstract	eng

2010 Health Sciences Research Day (MU)
Poster presentation abstracts for 2010 Health Sciences Research Day.